<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3660">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01479478</url>
  </required_header>
  <id_info>
    <org_study_id>18840</org_study_id>
    <nct_id>NCT01479478</nct_id>
  </id_info>
  <brief_title>Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy</brief_title>
  <official_title>Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators wish to determine if oral probiotic supplementation during the second half&#xD;
      of pregnancy decreases maternal GBS recto-vaginal colonization at 35-37 weeks' gestational&#xD;
      age, thereby decreasing need for maternal antibiotic administration at time of labor. The&#xD;
      importance of this study is that it may offer a safer alternative to antibiotic treatment of&#xD;
      group B Streptococcus (GBS) colonized pregnant women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Screening: All pregnant women prior to 28 weeks gestational age. Patients who choose to&#xD;
           enroll and who will not deliver at Lucile Packard Childrens Hospital at Stanford will&#xD;
           sign release of medical information forms for study personnel to access pregnancy&#xD;
           outcomes. Patients receiving obstetric care at any of the satellite research sites in&#xD;
           Santa Cruz will also be offered enrollment in the study.&#xD;
&#xD;
        2. Women will continue regular and routine obstetric care and clinic visits.&#xD;
&#xD;
        3. Placebo vs probiotic daily regimen: We plan to begin administration of product and&#xD;
           placebo at 20 weeks gestation, and no later than 28 weeks gestation until delivery. Once&#xD;
           a women is enrolled in the study, she will be randomized to either the placebo or the&#xD;
           probiotic group.&#xD;
&#xD;
        4. At the time of randomization, the patient will receive her month supply of 30 capsules;&#xD;
           The allocation arm will be double-blinded.&#xD;
&#xD;
        5. The investigators will schedule the women for routine monthly obstetric visits (more&#xD;
           often if clinically required) during which time they will also meet with one of the&#xD;
           investigators. The investigator at each monthly visit will provide an additional monthly&#xD;
           allotment of 30 capsules. The capsule bottle from the previous cycle will be collected&#xD;
           and dated if there are capsules remaining in the bottle. Remaining capsules will be&#xD;
           counted and refrigerated for future use.&#xD;
&#xD;
        6. The investigators will collect history data including safety data per the questionnaire&#xD;
           and will document compliance with the study.&#xD;
&#xD;
        7. GBS recto-vaginal screening: The investigators will enroll the women in the study and we&#xD;
           will perform the standard GBS colonization screening (using standard GBS recto-vaginal&#xD;
           cultures) at 36 weeks.&#xD;
&#xD;
        8. Additionally, subjects may opt to have serial vaginal swabs collected to assess&#xD;
           potential beneficial effects of probiotics on the vaginal microbiota and bacterial&#xD;
           vaginosis (BV) status. Vaginal swabs will be collected (either by study personnel or&#xD;
           self-collected by the study participant). Swabs will be inserted 1-2 inches into the&#xD;
           vaginal introitus and spun for 20 seconds and then withdrawn. Swabs will be collected at&#xD;
           the following time points: prior to probiotic/placebo initiation, every 1-4 weeks from&#xD;
           time of enrollment to time of delivery, and postpartum serially up to 12 months. These&#xD;
           swabs will be stored at -20 degrees Celsius or colder for additional microbiologic&#xD;
           analyses.&#xD;
&#xD;
        9. Additionally, placental tissue may be collected at time of delivery for possible future&#xD;
           microbiome and/or other analyses.&#xD;
&#xD;
       10. Women who suffer a premature rupture of the membranes, deliver before 36 weeks&#xD;
           gestation, or go into labor before the GBS culture result is available, will receive the&#xD;
           standard GBS antibiotic prophylaxis.&#xD;
&#xD;
       11. Labor: The patient will receive standard delivery and newborn care. Patients with a&#xD;
           positive GBS culture will be treated with standard antibiotics in labor.&#xD;
&#xD;
       12. Postpartum and neonatal care: The patient will receive routine postpartum care per the&#xD;
           obstetric team. Data regarding her postpartum course and neonatal outcomes will be&#xD;
           collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">July 26, 2017</completion_date>
  <primary_completion_date type="Actual">July 26, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Count of Participants With Positive Group B Streptococcus Rectovaginal Colonization Status at 35- 37 Weeks' Gestational Age</measure>
    <time_frame>35 to 37 weeks gestational age</time_frame>
    <description>Gestational age is given in a format of full weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Urinary Tract Infection</measure>
    <time_frame>From enrollment up to delivery hospitalization (up to 42 weeks gestation)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Intrapartum Chorioamnionitis</measure>
    <time_frame>From time of labor onset until delivery (up to 42 weeks of gestation)</time_frame>
    <description>Intrapartum chorioamnionitis is maternal temperature above 38.0 degrees Celsius and one or more of the following findings: fetal tachycardia; maternal tachycardia; uterine tenderness; purulent or malodorous amniotic fluid, or elevated maternal white blood cell count.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Endometritis</measure>
    <time_frame>From time of delivery up to 6 weeks postpartum</time_frame>
    <description>Endometritis is a uterine (myometrial) infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Cellulitis</measure>
    <time_frame>From time of delivery up to 6 weeks postpartum</time_frame>
    <description>Cellulitis is a bacterial skin infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Bacteremia</measure>
    <time_frame>From time of labor onset up to 6 weeks postpartum</time_frame>
    <description>Bacteremia is defined as presence of bacteria in the blood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Sepsis</measure>
    <time_frame>From labor onset up to 6 weeks postpartum</time_frame>
    <description>Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated response of the body to an infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Other Infectious Morbidity</measure>
    <time_frame>From time of labor onset up to 6 weeks postpartum</time_frame>
    <description>Other infectious morbidity included maternal mastitis or pneumonia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gestational Age at Delivery</measure>
    <time_frame>At time of delivery (up to 42 weeks of gestation)</time_frame>
    <description>Gestational age at delivery is presented as weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apgar Score at 1 and 5 Minutes Following Delivery</measure>
    <time_frame>At time of delivery (up to 42 weeks of gestation)</time_frame>
    <description>Apgar score is a measure to quickly assess the neonatal health status from time of delivery. Score ranges from 0-10. Lower scores correspond to worse health state; neonates with scores below 5 are considered to have poor prognosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Bilirubin Level</measure>
    <time_frame>Up to 14 days following delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal C-reactive Protein Level</measure>
    <time_frame>Up to 14 days following delivery</time_frame>
    <description>Maximum neonatal C-reactive protein level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Neonates Requiring a &quot;Rule-out Sepsis Evaluation&quot;</measure>
    <time_frame>Up to 14 days following delivery</time_frame>
    <description>Outcome was based on performance of neonatal blood culture.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Neonates With Sepsis</measure>
    <time_frame>Up to 14 days following delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Neonates With Pneumonia</measure>
    <time_frame>Up to 14 days following delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Neonates With Meningitis</measure>
    <time_frame>Up to 14 days following delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Neonates With Intensive-care Unit Admission</measure>
    <time_frame>Up to 14 days following delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Neonatal Hospital Stay</measure>
    <time_frame>Up to 14 days following delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">251</enrollment>
  <condition>Infection</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Probiotic dietary supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Probiotic dietary supplement one capsule once per day until delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsule, one daily until delivery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One placebo capsule daily.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Sugar pill</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic dietary supplement</intervention_name>
    <description>Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
    <arm_group_label>Probiotic dietary supplement</arm_group_label>
    <other_name>Other Names:</other_name>
    <other_name>Jarrow's fem-dophilus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Pregnant women between 20-28 weeks gestation.&#xD;
&#xD;
          2. 18 years of age or older.&#xD;
&#xD;
          3. Singleton gestation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Preexisting morbidity: Immunocompromised status (HIV +; malignancy; history of organ&#xD;
             transplant; chronic steroid therapy; autoimmune disease requiring treatment during&#xD;
             pregnancy, and other immunocompromised states); Type 1 diabetes and type 2&#xD;
             diabetes;congenital cardiac disease and cardiac valvular disease requiring antibiotic&#xD;
             prophylaxis during procedure/labor; pulmonary disease (except mild asthma); renal&#xD;
             disease; chronic hepatic disease (Hepatitis B, C); inflammatory bowel disease (Crohn's&#xD;
             disease or ulcerative colitis); stomach or duodenal ulcer; bowel resection, gastric&#xD;
             bypass, and chronic indwelling venous, bladder, or gastric catheter.&#xD;
&#xD;
          2. Multi-fetal gestation.&#xD;
&#xD;
          3. Use of probiotics preparations in the 3 months prior to beginning of the study&#xD;
             treatment or use of any additional probiotics preparations (other than study&#xD;
             treatment) at any time during the study period (including over the counter food&#xD;
             supplements such as Activia, BioK, other oral or vaginal probiotics products (BUT not&#xD;
             including other common forms of yogurt).&#xD;
&#xD;
          4. Chronic (daily) use of broad spectrum antibiotics.&#xD;
&#xD;
          5. History of infant with GBS sepsis.&#xD;
&#xD;
          6. Intrauterine Growth Restriction (IUGR), Fetal Anomalies-major diagnosed at time of&#xD;
             second trimester anatomy ultrasound&#xD;
&#xD;
          7. Anticipated delivery &lt;35 wks for maternal/fetal indication&#xD;
&#xD;
          8. Placenta previa or accreta (with anticipated delivery prior to 35 weeks)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natali Aziz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University School of Medicine/Lucile Packard Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aptos Women's Health Center</name>
      <address>
        <city>Aptos</city>
        <state>California</state>
        <zip>95003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dominican Hospital</name>
      <address>
        <city>Santa Cruz</city>
        <state>California</state>
        <zip>95065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University School of Medicine/Lucile Packard Children's Hospital</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>November 22, 2011</study_first_submitted>
  <study_first_submitted_qc>November 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2011</study_first_posted>
  <results_first_submitted>July 18, 2018</results_first_submitted>
  <results_first_submitted_qc>August 14, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 20, 2018</results_first_posted>
  <last_update_submitted>August 14, 2018</last_update_submitted>
  <last_update_submitted_qc>August 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Natali Aziz</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 19, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/78/NCT01479478/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/78/NCT01479478/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Only expecting mothers were enrolled in this study. Neonatal data were collected from respective pregnancies, however, the neonates were not considered to be enrolled in this study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Probiotic Dietary Supplement</title>
          <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="125"/>
                <participants group_id="P2" count="126"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="125"/>
                <participants group_id="P2" count="126"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Probiotic Dietary Supplement</title>
          <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="125"/>
            <count group_id="B2" value="126"/>
            <count group_id="B3" value="251"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.4" spread="5.7"/>
                    <measurement group_id="B2" value="31.9" spread="5.3"/>
                    <measurement group_id="B3" value="31.7" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="251"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Non-Hispanic white</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Hispanic other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-pregnancy Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.1" spread="6.5"/>
                    <measurement group_id="B2" value="26.0" spread="7.5"/>
                    <measurement group_id="B3" value="26.1" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Count of Participants With Positive Group B Streptococcus Rectovaginal Colonization Status at 35- 37 Weeks' Gestational Age</title>
        <description>Gestational age is given in a format of full weeks.</description>
        <time_frame>35 to 37 weeks gestational age</time_frame>
        <population>Participants with available data were included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Positive Group B Streptococcus Rectovaginal Colonization Status at 35- 37 Weeks' Gestational Age</title>
          <description>Gestational age is given in a format of full weeks.</description>
          <population>Participants with available data were included in the analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
                <count group_id="O2" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.87</p_value>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Urinary Tract Infection</title>
        <time_frame>From enrollment up to delivery hospitalization (up to 42 weeks gestation)</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Urinary Tract Infection</title>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="123"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Intrapartum Chorioamnionitis</title>
        <description>Intrapartum chorioamnionitis is maternal temperature above 38.0 degrees Celsius and one or more of the following findings: fetal tachycardia; maternal tachycardia; uterine tenderness; purulent or malodorous amniotic fluid, or elevated maternal white blood cell count.</description>
        <time_frame>From time of labor onset until delivery (up to 42 weeks of gestation)</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Intrapartum Chorioamnionitis</title>
          <description>Intrapartum chorioamnionitis is maternal temperature above 38.0 degrees Celsius and one or more of the following findings: fetal tachycardia; maternal tachycardia; uterine tenderness; purulent or malodorous amniotic fluid, or elevated maternal white blood cell count.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Endometritis</title>
        <description>Endometritis is a uterine (myometrial) infection.</description>
        <time_frame>From time of delivery up to 6 weeks postpartum</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Endometritis</title>
          <description>Endometritis is a uterine (myometrial) infection.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Cellulitis</title>
        <description>Cellulitis is a bacterial skin infection.</description>
        <time_frame>From time of delivery up to 6 weeks postpartum</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Cellulitis</title>
          <description>Cellulitis is a bacterial skin infection.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="123"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Bacteremia</title>
        <description>Bacteremia is defined as presence of bacteria in the blood.</description>
        <time_frame>From time of labor onset up to 6 weeks postpartum</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Bacteremia</title>
          <description>Bacteremia is defined as presence of bacteria in the blood.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Sepsis</title>
        <description>Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated response of the body to an infection.</description>
        <time_frame>From labor onset up to 6 weeks postpartum</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Sepsis</title>
          <description>Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated response of the body to an infection.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Other Infectious Morbidity</title>
        <description>Other infectious morbidity included maternal mastitis or pneumonia.</description>
        <time_frame>From time of labor onset up to 6 weeks postpartum</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Other Infectious Morbidity</title>
          <description>Other infectious morbidity included maternal mastitis or pneumonia.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gestational Age at Delivery</title>
        <description>Gestational age at delivery is presented as weeks.</description>
        <time_frame>At time of delivery (up to 42 weeks of gestation)</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Gestational Age at Delivery</title>
          <description>Gestational age at delivery is presented as weeks.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="117"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.6" lower_limit="39.0" upper_limit="40.6"/>
                    <measurement group_id="O2" value="39.4" lower_limit="38.7" upper_limit="40.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apgar Score at 1 and 5 Minutes Following Delivery</title>
        <description>Apgar score is a measure to quickly assess the neonatal health status from time of delivery. Score ranges from 0-10. Lower scores correspond to worse health state; neonates with scores below 5 are considered to have poor prognosis.</description>
        <time_frame>At time of delivery (up to 42 weeks of gestation)</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Apgar Score at 1 and 5 Minutes Following Delivery</title>
          <description>Apgar score is a measure to quickly assess the neonatal health status from time of delivery. Score ranges from 0-10. Lower scores correspond to worse health state; neonates with scores below 5 are considered to have poor prognosis.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="113"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At 1 minute</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="7" upper_limit="9"/>
                    <measurement group_id="O2" value="8" lower_limit="8" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At 5 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="9" upper_limit="9"/>
                    <measurement group_id="O2" value="9" lower_limit="9" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Bilirubin Level</title>
        <time_frame>Up to 14 days following delivery</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Bilirubin Level</title>
          <population>Participants with available data were included in the analysis.</population>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="94"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.4" lower_limit="5.1" upper_limit="9.6"/>
                    <measurement group_id="O2" value="6.5" lower_limit="4.9" upper_limit="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal C-reactive Protein Level</title>
        <description>Maximum neonatal C-reactive protein level</description>
        <time_frame>Up to 14 days following delivery</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal C-reactive Protein Level</title>
          <description>Maximum neonatal C-reactive protein level</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>mg/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" lower_limit="0.3" upper_limit="4.1"/>
                    <measurement group_id="O2" value="1.2" lower_limit="0.4" upper_limit="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Neonates Requiring a &quot;Rule-out Sepsis Evaluation&quot;</title>
        <description>Outcome was based on performance of neonatal blood culture.</description>
        <time_frame>Up to 14 days following delivery</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Neonates Requiring a &quot;Rule-out Sepsis Evaluation&quot;</title>
          <description>Outcome was based on performance of neonatal blood culture.</description>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Neonates With Sepsis</title>
        <time_frame>Up to 14 days following delivery</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Neonates With Sepsis</title>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Neonates With Pneumonia</title>
        <time_frame>Up to 14 days following delivery</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Neonates With Pneumonia</title>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Neonates With Meningitis</title>
        <time_frame>Up to 14 days following delivery</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Neonates With Meningitis</title>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Neonates With Intensive-care Unit Admission</title>
        <time_frame>Up to 14 days following delivery</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Neonates With Intensive-care Unit Admission</title>
          <population>Participants with available data were included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Neonatal Hospital Stay</title>
        <time_frame>Up to 14 days following delivery</time_frame>
        <population>Participants with available data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic Dietary Supplement</title>
            <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Neonatal Hospital Stay</title>
          <population>Participants with available data were included in the analysis.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="113"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="2" upper_limit="3"/>
                    <measurement group_id="O2" value="2" lower_limit="2" upper_limit="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From enrollment up to 6 weeks following delivery.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Probiotic Dietary Supplement</title>
          <description>Probiotic dietary supplement one capsule once per day until delivery.&#xD;
Probiotic dietary supplement: Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo capsule, one daily until delivery.&#xD;
Placebo: One placebo capsule daily.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Any other anticipated or unanticipated life-threatening event:intra-uterine fetal growth restriction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Natali Aziz, MD</name_or_title>
      <organization>Stanford University</organization>
      <phone>650-725-5720</phone>
      <email>mfmresearch@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

